Skip to content
Malawi Clinical GuidelinesGuidelinesGet app

14.1

Classification of individual ARVs

Clinical HIV Guidelines, 5th Edition, 2022. Chapter 14, Understanding ART regimens and formulations.

Clinical description

  • Main classification is based on mode of action against HIV replication.
  • Sub-classification is based on biochemical structure of the drug.
  • Only ARVs with the same dosing interval are available as fixed-dose combinations.

Table 14: Classification of ARVs Mode of action Biochem. structure Abbrev. ARVs Dosing interval AZT 12-hourly 12- or 24- Nucleosides NRTI 3TC, ABC hourly Reverse Transcriptase Entecavir (ETV)* 24-hourly Inhibitors Nucleotide NtRTI TDF 24-hourly NVP 12-hourly Non-Nucleosides NNRTI EFV 24-hourly ATV/r 24-hourly Protease Inhibitors PI DRV 12-hourly LPV/r 12-hourly Integrase Strand INSTI DTG 24-hourly Transfer Inhibitor *ETV is used for treating chronic HepB (not HIV). Needed for HIV/HepB co-infected patients who cannot take TDF/3TC containing ART (e.g. children under 30kg, patients with renal insufficiency)

Table 14 — Classification of ARVs
Table 14 — Classification of ARVs. Open the image to zoom.
Spotted an error? Report it by

Need this without data?

The app holds every guideline on your device, with calculators, bookmarks and notes.